We are reimagining what innovation looks like in the life sciences and are committed to providing the tools and expertise and that can inspire an infinite number of scientific solutions.
Innovation is at the core of the value that we deliver to our customers. Our business is research driven and innovation focused. In 2021, we invested €351 million in R&D, supporting the of new innovations designed to meet our customers' most unmet needs – from antibodies to water purification systems.
Our research activities focus on developing innovative technologies for laboratory and life science applications in government and academic labs, the biopharmaceutical industry and the industrial sector. We continue to focus on digitized and automated labware, DNA purification for downstream applications, and emerging chemical synthesis, as well as software for our BioContinuum™ Platform to accelerate Biopharma 4.0. In addition, our teams remain dedicated to delivering advancements in our core portfolios, such as filtration, pure lab water, and diagnostic solutions.
Our M Lab™ Collaboration Centers offer vibrant collaboration spaces where our customers can explore ideas, learn innovative techniques, and work side by side with our scientists and engineers to solve critical process development challenges. This global network of non-GMP labs, designed specifically for customers, offer the flexibility to troubleshoot and test in our facility without impacting your production line. Located in key biopharma hubs around the world, our experts are ready to collaborate with your experts to solve your toughest problems – together.
€276K invested in R&D
2,000 R&D employees
18,500 new products
10 M Lab™ Collaboration Centers Latest Stories